H

Hospital da Luz | Lisboa

Research site

(Unclaimed)

Location

Avenida Lusíada, 100, Lisbon, Lisbon, Portugal

Site insights

Top conditions

Top treatments

9-ING-41

Azacitidine

Ontamalimab

Ribociclib

Magrolimab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 7 total trials

9-ING-41 in Patients with Advanced Cancers

GSK-3β is a potentially important therapeutic target in human malignancies. The Actuate 1801 Phase 1/2 study is designed to evaluate the safety and e...

Active, not recruiting

Neoplasm of Lung

Neoplasms Pancreatic

Drug: Gemcitabine - 21 day cycle

Drug: 9-ING-41

Improving CRT Outcome With Non-Invasive Cardiac Mapping (ICONIC-M)

The ICONIC-M study is a multicenter randomized controlled study to assess patient response to CRT comparing ECGI map guided left ventricular lead pla...

Enrolling

Heart Failure With Reduced Ejection Fraction

Device: Pre-implantation planning

Device: Post-implantation assessment

Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer (RIBOLARIS)

This is an open-label, multicenter international trial in men and women with primary operable HR+/HER2-, ki67≥20%, grade 2 or 3 and stage II breast c...

Enrolling

Breast Cancer Stage II

Drug: Ribociclib (adjuvant)

Drug: Chemotherapy (adjuvant)